Analysts Turn Bullish on BioNTech Stock Amid Volatility

BioNTech SE ADR (NASDAQ:BNTX) stock is up 2.8% to trade at $825.41 at last glance, after an Evercore ISI upgrade to "outperform" from "in-line." The analyst in question also hiked its price target to $125 from $110, calling the volatility on the heels of Robert F. Kennedy Jr.'s nomination to the Department of Health and Human Services a buying opportunity for investors. Plus, Berenberg initiated coverage with a "buy" rating and $130 price target. Shares are bouncing off a pullback to their lowest close sinc ...